| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |